Second Sight Medical Product Inc Hinted at 44.8 Percentages

In Health Care sector the Second Sight Medical Products are displayed with the target price of 21 USD on its stock. This makes the analyst to expect that there will be a potential upside of 44.8 percentage form the starting price of 14.5 USD.

Overview of Second Sight Medical Product:

Second Sight Medical Product Inc as the SYMBOL code NASDAQ: EYES had the stock rating, which is noted as Coverage Initiated with the instruction being set as ‘BUY’ this morning by analysts at H.C. Wainwright. The 50 day moving average of Second Sight Medical Product Inc NASDAQ: EYES are 13.92 USD and share price is recorded as 13.56 USD in 200 day moving average. It has the 24.02 USD as share price for 52 weeks.

It is a high share price, whereas the year share price is low with 8.05 USD. Second Sight Medical Product Inc is the company which manufactures and develops the medical devices like a visual prosthetic for restoring the functional vision for the people who are blind.

The Argus II System gives treatment for the outer retinal degenerations like retinitis pigmentosa (RP). The artificial vision is provided by the Argus II System, which is totally different from the vision that normal people have. The small portable computer and a pair of glass with a mini video camera are implanted in the Argus II Retinal Prosthesis System. The Argus II got the approval from Conformite Europeenne (CE) and also from the Food and Drug Administration (FDA) of United State for marketing and sales of the products. The marketing of the Argus II System is also done by the company in the countries such as Turkey and Canada. And it is also done in the medical center of Saudi Arabia.

The Argus II Retinal Prosthesis System:

It is used to give the electrical stimulation of the retina for bringing out the visual perception blind people seriously to deep retinitis pigmentosa. Surgically the epiretinal prosthesis is implanted in and on the eye, which involves an antenna, an electrode array, an electronic case, whereas the external device has the cable, glass and a video processing unit (VPU). It is approved by the Federal of Unites State to give the electrical stimulation of the retina, which will improve the visual perception for the blind patients. It is not experimented for view the effectiveness of this device.

Pallavi Tiple writes news on industry, businesses, technologies, media, and current affairs and also produces the content on daily basis regarding latest trends, markets, promotions, and events for Medical Device News. She enjoys reading and painting in her leisure time. She can be reached at pallavi@medicaldevicenews.net